Clinical trial
Immunotherapy of the Paraneoplastic Syndromes
NCT00378326 · Rockefeller University, Other · Completed
Key facts
| NCT number | NCT00378326 |
|---|---|
| Title | Immunotherapy of the Paraneoplastic Syndromes |
| Official title | Immunotherapy of the Paraneoplastic Syndromes |
| Lead sponsor | Rockefeller University, Other |
| Status | Completed |
| Study type | Interventional |
| Conditions | Paraneoplastic Syndromes |
| Intervention type | Drug |
| Interventions | Tacrolimus |
| Enrollment | 26 |
| Start date | Apr 1, 2006 |
| Primary completion | May 1, 2014 |
| Completion | May 1, 2014 |
| First posted | Sep 20, 2006 |
| Last update posted | Sep 18, 2023 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: